Expertise in
24
conditions

Jordi Manera-Diaz

Central Parkway, 
Newcastle Upon Tyne, ENG, GB 
Expertise in
24
conditions
Central Parkway, 
Newcastle Upon Tyne, ENG, GB 

Overview

Jordi Manera-Diaz practices practicing medicine in Newcastle Upon Tyne, United Kingdom.

Manera-Diaz is highly rated in 24 conditions, according to our data. Their clinical expertise encompasses Pompe Disease, Limb-Girdle Muscular Dystrophy, Dysferlinopathy, and Delta-Sarcoglycanopathy.

They are actively involved in clinical research, co-authoring 234 peer reviewed articles and participating in 2 clinical trials.

Locations

Central Parkway, Newcastle Upon Tyne, ENG, United Kingdom

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase 1/2, Open-Label, Ascending-Dose Clinical Study to Evaluate the Safety and Preliminary Efficacy of AT845, an AAV8-Delivered Gene Transfer Therapy in Patients With Late Onset Pompe Disease
A Phase 1/2, Open-Label, Ascending-Dose Clinical Study to Evaluate the Safety and Preliminary Efficacy of AT845, an AAV8-Delivered Gene Transfer Therapy in Patients With Late Onset Pompe Disease
Enrollment Status: Active_not_recruiting
Publish Date: September 02, 2026
Intervention Type: Genetic
Study Phase: Phase 1/Phase 2
Journey: A Global, Multicenter, Longitudinal Study of the Natural History of Subjects With Limb Girdle Muscular Dystrophy (LGMD) Type 2E (LGMD2E/R4), Type 2D (LGMD2D/R3), Type 2C (LGMD2C/R5), and Type 2A (LGMD2A/R1)
Journey: A Global, Multicenter, Longitudinal Study of the Natural History of Subjects With Limb Girdle Muscular Dystrophy (LGMD) Type 2E (LGMD2E/R4), Type 2D (LGMD2D/R3), Type 2C (LGMD2C/R5), and Type 2A (LGMD2A/R1)
Enrollment Status: Active_not_recruiting
Publish Date: November 06, 2025
View 1 Less Clinical Trial

231 Total Publications

A disease progression model comparing the long-term mobility and respiratory outcomes of adults with late-onset Pompe disease receiving cipaglucosidase alfa plus miglustat versus alglucosidase alfa.
A disease progression model comparing the long-term mobility and respiratory outcomes of adults with late-onset Pompe disease receiving cipaglucosidase alfa plus miglustat versus alglucosidase alfa.
Journal: Journal of comparative effectiveness research
Published: July 15, 2026

Frequently Asked Questions about Jordi Manera-Diaz

Is Jordi Manera-Diaz a top-rated expert for Pompe Disease?

MediFind is an objective health platform that identifies experts based on real-world data. Jordi Manera-Diaz is classified as an Elite expert for Pompe Disease, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Jordi Manera-Diaz participate in research or clinical trials?

Yes. Jordi Manera-Diaz has published 231 articles and abstracts on conditions like Pompe Disease. You can view a list of Jordi Manera-Diaz's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Manera-Diaz's expertise for a condition
ConditionClose
View All 17 Advanced Conditions
View All 51 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile